Recent Advances in Anti-Tumour Necrosis Factor (TNF) Therapy in Rheumatoid Arthritis: Focus on the Soluble TNF Receptor p75 Fusion Protein, Etanercept

Author： Moreland L.W.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.11, Iss.3, 1999-03, pp. : 201-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Tumour Necrosis Factor in the Treatment of Rheumatoid Arthritis

By Pearce G.J.   Chikanza I.C.  

BioDrugs, Vol. 15, Iss. 3, 2001-03 ,pp. : 139-149

Adis International

Access to resources Recommend Favorite

Tumour Necrosis Factor- Blockers in Rheumatoid Arthritis: Review of the Clinical Experience

By Richard-Miceli C.   Dougados M.  

BioDrugs, Vol. 15, Iss. 4, 2001-04 ,pp. : 251-259

Adis International

Access to resources Recommend Favorite

Tumour Necrosis Factor in Sarcoidosis and its Potential for Targeted Therapy

By Baughman R.P.  

BioDrugs, Vol. 17, Iss. 6, 2003-01 ,pp. : 425-431

Adis International

Access to resources Recommend Favorite

Recent Advances in Therapy of Sepsis: Focus on Recombinant Bactericidal/Permeability-Increasing Protein (BPI)

By Elsbach P.  

BioDrugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 435-442

Adis International

Access to resources Recommend Favorite

Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis

By Garrood T.   Scott D.L.  

BioDrugs, Vol. 15, Iss. 8, 2001-08 ,pp. : 543-561

Adis International

Access to resources Recommend Favorite